SMMT FY 2023 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

SMMTSummit Therapeutics Inc.

$12B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$2M

Operating Income

-$90M

Net Income

-$615M

EPS (Diluted)

$-0.99

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$77M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$203M

Total Liabilities

$125M

Stockholders' Equity

$78M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$704,295	-100.0%
Gross Profit	-$2M	-$2M	-13.3%
Operating Income	-$90M	-$60M	-50.5%
Net Income	-$615M	-$79M	-680.5%